Literature DB >> 28925721

The more effective treatment of atrial fibrillation applying the natural compounds; as NADPH oxidase and ion channel inhibitors.

Samira Barangi1, A Wallace Hayes2, Gholamreza Karimi1,3.   

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia that occurs because of several different risk factors, e.g., valvular heart disease, coronary artery disease, age ≥75 years, hypertension and diabetes mellitus. One key risk factor that results in AF, is oxidative stress. Evidence suggests that there is a correlation between oxidative processes and the genesis of AF. Oxidative stress occurs when the generation of reactive oxygen species (ROS) increase due to excessive activity of enzymes including NADPH oxidase (NOX) and xanthine oxidase; or its degradation decrease by dysfunctional antioxidant enzyme systems, such as superoxide dismutase (SOD), catalase and glutathione peroxidase (GPx). Afterwards, elevated ROS may shift ion channel activity to increase AF susceptibility. The outbreak of AF continues to grow. Unfortunately, current treatment strategies may have limited efficacy or adverse effects. On the other hand, the inhibition of ROS formation and alteration of ion channel activity could be important therapeutic targets for prevention or treatments of AF. Additionally, many studies have been shown that several natural compounds have the ability to inhibit NADPH oxidases directly. This review focuses on natural compounds which specially inhibit NOX isoforms and have direct effects on ion channels, suggesting these compounds can be helpful in AF treatment.

Entities:  

Keywords:  Apocynin; Atrial fibrillation; Berberine; Curcumin; Reactive Oxygen Species; Resveratrol

Mesh:

Substances:

Year:  2017        PMID: 28925721     DOI: 10.1080/10408398.2017.1379000

Source DB:  PubMed          Journal:  Crit Rev Food Sci Nutr        ISSN: 1040-8398            Impact factor:   11.176


  11 in total

1.  Cardiac Fibroblasts Promote Ferroptosis in Atrial Fibrillation by Secreting Exo-miR-23a-3p Targeting SLC7A11.

Authors:  Dishiwen Liu; Mei Yang; Yajun Yao; Shanqing He; Youcheng Wang; Zhen Cao; Huiyu Chen; Yuntao Fu; Huafen Liu; Qingyan Zhao
Journal:  Oxid Med Cell Longev       Date:  2022-05-29       Impact factor: 7.310

2.  Cardioprotection stimulated by resveratrol and grape products prevents lethal cardiac arrhythmias in an animal model of ischemia and reperfusion.

Authors:  Francisco Sandro Menezes-Rodrigues; Paolo Ruggero Errante; Erisvaldo Amarante Araújo; Mariana Pontes Pacheco Fernandes; Michele Mendes da Silva; Marcelo Pires-Oliveira; Carla Alessandra Scorza; Fúlvio Alexandre Scorza; Murched Omar Taha; Afonso Caricati-Neto
Journal:  Acta Cir Bras       Date:  2021-05-07       Impact factor: 1.388

Review 3.  Therapeutic Potential of Polyphenols-Loaded Polymeric Nanoparticles in Cardiovascular System.

Authors:  Olga Pechanova; Ezgi Dayar; Martina Cebova
Journal:  Molecules       Date:  2020-07-22       Impact factor: 4.411

4.  Renal Fibrosis and Mitochondrial Damage.

Authors:  Jiao Qin; Zhang-Zhe Peng; Qian Li; Rui Wen; Li-Jian Tao
Journal:  Chin Med J (Engl)       Date:  2018-11-20       Impact factor: 2.628

Review 5.  Hypoxia-Inducible Factor-1: A Potential Target to Treat Acute Lung Injury.

Authors:  Yang Liu; Du Xiang; Hengcheng Zhang; Hanlin Yao; Yanfeng Wang
Journal:  Oxid Med Cell Longev       Date:  2020-11-17       Impact factor: 6.543

Review 6.  Research Progress on Natural Products' Therapeutic Effects on Atrial Fibrillation by Regulating Ion Channels.

Authors:  Jinshan He; Sicong Li; Yumeng Ding; Yujia Tong; Xuebin Li
Journal:  Cardiovasc Ther       Date:  2022-03-22       Impact factor: 3.023

7.  Mechanism of Action of Zhi Gan Cao Decoction for Atrial Fibrillation and Myocardial Fibrosis in a Mouse Model of Atrial Fibrillation: A Network Pharmacology-Based Study.

Authors:  Lei Gao; Chenjing Kan; Xin Chen; Shengsong Xu; Kaihu Shi
Journal:  Comput Math Methods Med       Date:  2022-06-09       Impact factor: 2.809

8.  Prediction of herbal medicines based on immune cell infiltration and immune- and ferroptosis-related gene expression levels to treat valvular atrial fibrillation.

Authors:  Feng Jiang; Weiwei Zhang; Hongdan Lu; Meiling Tan; Zhicong Zeng; Yinzhi Song; Xiao Ke; Fengxia Lin
Journal:  Front Genet       Date:  2022-09-28       Impact factor: 4.772

Review 9.  Possible protective effect of resolvin D1 on inflammation in atrial fibrillation: involvement of ER stress mediated the NLRP3 inflammasome pathway.

Authors:  Fatemeh Yarmohammadi; A Wallace Hayes; Gholamreza Karimi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-03       Impact factor: 3.000

Review 10.  Promising Antioxidative Effect of Berberine in Cardiovascular Diseases.

Authors:  Na An; Guoxia Zhang; Yingjian Li; Chao Yuan; Fan Yang; Lijing Zhang; Yonghong Gao; Yanwei Xing
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.